Glyburide

insulin ; Homo sapiens







292 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
201 3126626 Glibenclamide improves the response to insulin treatment in non-insulin-dependent diabetics with second failure to sulfonylurea therapy. 1988 3
202 3133266 Effects of the combination of insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents. 1988 Apr 4
203 3140992 The effects of glibenclamide treatment on insulin secretion and on insulin binding to erythrocytes in type II diabetes mellitus. 1988 1
204 3143744 Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. 1988 Dec 1
205 3147830 In vivo action of glibenclamide in obese subjects with mild type 2 (non-insulin dependent) diabetes. 1988 Jun 1
206 3149105 Rapid improvement in insulin binding to erythrocyte insulin receptors in non-insulin-dependent diabetes mellitus during therapy. 1988 Jul-Sep 2
207 2890501 Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea. 1987 Sep-Oct 2
208 2894389 Acute effect of glibenclamide upon red cell transglutaminase activity in diabetic patients. 1987 Dec 1
209 3034949 In vitro study of cultured human insulinoma cells: evidence of abnormal sensitivity to glucose. 1987 Jul 1
210 3100365 Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients. 1987 Feb 1
211 3104218 Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes. 1987 Feb 1
212 3106656 Addition of sulfonylurea to insulin treatment in poorly controlled type II diabetes. A double-blind, randomized clinical trial. 1987 May 8 4
213 3111514 The paradoxical effect of cimetidine and ranitidine on glibenclamide pharmacokinetics and pharmacodynamics. 1987 Jun 1
214 3115853 Mechanism of exercise-induced hypoglycemia during sulfonylurea treatment. 1987 Oct 1
215 3116364 Effect of glyburide on glycogen metabolism in cultured rat hepatocytes. 1987 Oct 2
216 3117609 Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects. 1987 Nov 2
217 3117833 Acute effect of glyburide on insulin sensitivity in type I diabetic patients. 1987 Nov 6
218 3118579 [Long-term effect of combination glibenclamide-insulin treatment in the secondary failure of sulfonylurea therapy--results of a one-year double blind study]. 1987 Sep 11 3
219 3119405 Effect of glyburide in type II diabetes mellitus. Studies of monocyte membrane fluidity, lipid composition, and insulin binding. 1987 Dec 1
220 3119407 Glyburide modulates insulin-mediated locomotor response of confluent cell cultures to wounding. 1987 Dec 3
221 3123184 Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment. 1987 Nov-Dec 2
222 3126223 Effects of metformin and glibenclamide on insulin receptors in fibroblasts and tumor cells in vitro. 1987 Dec 5
223 2878704 Glucose tolerance during long term treatment with a somatostatin analogue. 1986 Nov 22 1
224 3084315 Effect of glibenclamide in insulin-treated diabetic patients with a residual insulin secretion. 1986 Feb 1
225 3085419 Interindividual variation in the absorption of glibenclamide in man. 1986 Apr 1
226 3092851 Effect of oral verapamil on glibenclamide stimulated insulin secretion. 1986 Aug 2
227 3095909 Potentiation by previous nutrients of glibenclamide-induced insulin release in man. An effect which is counteracted by meal-induced retardation of drug absorption. 1986 Oct 2
228 3097384 [Mechanism of action of combined administration of glibenclamide and insulin in type II diabetics with secondary failure of oral treatment]. 1986 Oct 15 2
229 3098013 Changes in insulin receptor functions of the erythrocyte by treatment of non-insulin-dependent diabetes mellitus (NIDDM) patients with glibenclamide and diet control. 1986 Jul-Sep 1
230 2951088 The effect of glibenclamide administration on insulin sensitivity and insulin binding to monocytes in normal subjects. 1985 Sep 3
231 3919531 Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone. 1985 1
232 3923453 Glyburide: a second-generation sulfonylurea hypoglycemic agent. History, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects. 1985 Mar-Apr 1
233 3923833 The 24-hour effects of glyburide and chlorpropamide after chronic treatment of type II diabetic patients. 1985 May 1
234 3923961 Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone. 1985 Jun 1
235 3924948 Sulfonylureas in insulin-dependent (type I) diabetes: evidence for an extrapancreatic effect in vivo. 1985 Aug 7
236 3931459 Longitudinal evaluation of the effects of sulfonylurea therapy in subjects with type II diabetes mellitus. 1985 Sep 20 2
237 3931466 Effects of glyburide therapy on lipoproteins in non-insulin-dependent diabetes mellitus. 1985 Sep 20 2
238 3931537 Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients. 1985 3
239 3933984 Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics. 1985 2
240 3934860 [Combination treatment of insulin dependent elderly diabetics (type II diabetes) with the sulfonylurea compound glibenclamide]. 1985 Sep-Oct 1
241 3935120 Comparison of acute and prolonged effects of glibenclamide and chlorpropamide in patients with non-insulin-dependent diabetes. 1985 2
242 3935405 [Combined treatment of type-2 diabetics with insulin and glibenclamide after secondary drug failure. Double-blind, insulin-placebo-controlled crossover study]. 1985 Dec 20 1
243 6376033 The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes. 1984 May-Jun 2
244 6424413 The acyl-amino-alkyl benzoic acid residue and the sulfonylurea containing residue of glibenclamide affect different aspects of beta-cell function. 1984 Feb 1
245 6428843 Effect of glyburide on metabolic control and insulin binding in insulin-dependent diabetes mellitus. 1984 May-Jun 2
246 6429023 Hyperglycaemic clamp and insulin binding to isolated monocytes before and after glibenclamide treatment of mild type II diabetics. 1984 May 1
247 6432273 [Effect of glibenclamide therapy on the plasma insulin level in non-insulin-dependent diabetes]. 1984 Mar 1
248 6432610 Mechanism of improvement in glucose metabolism after chronic glyburide therapy. 1984 Sep 1
249 6435371 Improved diabetic control in insulin-dependent diabetics treated with insulin and glibenclamide. 1984 Sep 2
250 6437842 Glibenclamide pharmacokinetics in acarbose-treated type 2 diabetics. 1984 1